Local gentamicin application does not interfere with bone healing in a rat model

Bone

Volumn 55, Issue 2, 2013, Pages 298-304

  Fassbender, M ^a   Minkwitz, S ^a   Kronbach, Z ^a   Strobel, C ^a   Kadow Romacker, A ^a   Schmidmaier, G ^b   Wildemann, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bone healing; Gentamicin; Infection prophylaxis; Local drug delivery; Small animal model

Indexed keywords

GENTAMICIN; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE DENSITY; BONE INFECTION; BONE MASS; BONE MINERALIZATION; CONTROLLED STUDY; DRUG COATING; DRUG EFFICACY; EXTERNAL FIXATOR; FEMALE; FRACTURE HEALING; HISTOPATHOLOGY; IMAGE RECONSTRUCTION; IN VIVO STUDY; INFECTION RISK; INTRAMEDULLARY NAIL; KIRSCHNER WIRE; LOADING TEST; MECHANICAL TORSION; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; NONHUMAN; OSTEOTOMY; RAT; RISK REDUCTION; THREE DIMENSIONAL IMAGING; TIBIA FRACTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BONE WIRES; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FRACTURE FIXATION, INTRAMEDULLARY; FRACTURE HEALING; GENTAMICINS; OSTEOTOMY; RATS; RATS, SPRAGUE-DAWLEY; TIBIAL FRACTURES;

EID: 84878123569     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.04.018     Document Type: Article

References (30)

1. Coles C.P., Gross M. Closed tibial shaft fractures: management and treatment complications. A review of the prospective literature. Can. J. Surg. 2000, 43:256-262.
2. Gustilo R.B., Mendoza R.M., Williams D.N. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J. Trauma 1984, 24:742-746.
3. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987, 237:1588-1595.
4. Murray C.K., Obremskey W.T., Hsu J.R., Andersen R.C., Calhoun J.H., Clasper J.C., et al. Prevention of infections associated with combat-related extremity injuries. J. Trauma 2011, 71:S235-S257.
5. Patzakis M.J., Wilkins J. Factors influencing infection rate in open fracture wounds. Clin. Orthop. Relat. Res. 1989, 36-40.
6. Antoci V., Adams C.S., Hickok N.J., Shapiro I.M., Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin. Orthop. Relat. Res. 2007, 462:200-206.
7. Chang Y., Goldberg V.M., Caplan A.I. Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells. Clin. Orthop. Relat. Res. 2006, 452:242-249.
8. Isefuku S., Joyner C.J., Simpson A.H. Gentamicin may have an adverse effect on osteogenesis. J. Orthop. Trauma 2003, 17:212-216.
9. Duewelhenke N., Krut O., Eysel P. Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob. Agents Chemother. 2007, 51:54-63.
10. Perry A.C., Prpa B., Rouse M.S., Piper K.E., Hanssen A.D., Steckelberg J.M., et al. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin. Orthop. Relat. Res. 2003, 95-100.
11. Haleem A.A., Rouse M.S., Lewallen D.G., Hanssen A.D., Steckelberg J.M., Patel R. Gentamicin and vancomycin do not impair experimental fracture healing. Clin. Orthop. Relat. Res. 2004, 22-24.
12. Schmidmaier G., Wildemann B., Stemberger A., Haas N.P., Raschke M. Biodegradable poly(d, l-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res, Appl Biomater 2001, 58:449-455.
13. Vester H., Wildemann B., Schmidmaier G., Stockle U., Lucke M. Gentamycin delivered from a PDLLA coating of metallic implants: in vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Injury 2010, 41:1053-1059.
14. Strobel C., Schmidmaier G., Wildemann B. Changing the release kinetics of gentamicin from poly(d, l-lactide) implant coatings using only one polymer. Int. J. Artif. Organs 2011, 34:304-316.
15. Strobel C., Kadow-Romacker A., Witascheck T., Schmidmaier G., Wildemann B. Evaluation of process parameter of an automated dip-coating. Mater. Lett. 2011, 65:3621-3624.
16. Lucke M., Schmidmaier G., Sadoni S., Wildemann B., Schiller R., Haas N., et al. Gentamicin coating of metallic implants reduces implant related osteomyelitis in rats. Bone 2003, 32:521-531.
17. Lucke M., Wildemann B., Sadoni S., Surke C., Schiller R., Stemberger A., et al. Systemic versus local application of gentamicin in prophylaxis of implant related osteomyelitis in a rat model. Bone 2005, 36:770-778.
18. Kratzel C., Bergmann C., Duda G., Greiner S., Schmidmaier G., Wildemann B. Characterization of a rat osteotomy model with impaired healing. BMC Musculoskelet. Disord. 2008, 9:135.
19. Schmidmaier G., Wildemann B., Melis B., Krummrey G., Einhorn A., Haas N., et al. Development and characterization of a standard closed tibial fracture model in the rat. Eur J Trauma 2004, 30:35-42.
20. Yeom H., Blanchard S., Kim S., Zunt S., Chu T.M. Correlation between micro-computed tomography and histomorphometry for assessment of new bone formation in a calvarial experimental model. J. Craniofac. Surg. 2008, 19:446-452.
21. Ince A., Schutze N., Hendrich C., Jakob F., Eulert J., Lohr J.F. Effect of polyhexanide and gentamycin on human osteoblasts and endothelial cells. Swiss Med. Wkly. 2007, 137:139-145.
22. Strobel C., Bormann N., Kadow-Romacker A., Schmidmaier G., Wildemann B. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J. Control. Release 2011, 156:37-45.
23. Rathbone C.R., Cross J.D., Brown K.V., Murray C.K., Wenke J.C. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J. Orthop. Res. 2011, 29:1070-1074.
24. Ince A., Schutze N., Hendrich C., Thull R., Eulert J., Lohr J.F. In vitro investigation of orthopedic titanium-coated and brushite-coated surfaces using human osteoblasts in the presence of gentamycin. J. Arthroplasty 2008, 23:762-771.
25. Kim S.G., Chung T.Y., Kim M.S., Lim S.C. The effect of high local concentrations of antibiotics on demineralized bone induction in rats. J. Oral Maxillofac. Surg. 2004, 62:708-713.
26. Buchholz H.W., Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 1970, 41:511-515.
27. Lewis G. Properties of antibiotic-loaded acrylic bone cements for use in cemented arthroplasties: a state-of-the-art review. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 89:558-574.
28. Lindsey R.W., Probe R., Miclau T., Miclau T., Alexander J.W., et al. The effects of antibiotic-impregnated autogeneic cancellous bone graft on bone healing. Clin. Orthop. Relat. Res. 1993, 303-312.
29. Nelson C.L., McLaren S.G., Skinner R.A., Smeltzer M.S., Thomas J.R., Olsen K.M. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J. Orthop. Res. 2002, 20:643-647.
30. Fuchs T., Stange R., Schmidmaier G., Raschke M.J. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch. Orthop. Trauma Surg. 2011, 131:1419-1425.